Anticoagulation Intensity of Rivaroxaban for Stroke Patients at a Special Low Dosage in Japan

OBJECTIVES: In Japan, low-dose rivaroxaban [15 mg QD/10 mg QD for creatinine clearance of 30–49 mL/min] was approved for clinical use in NVAF patients partly because of its unique pharmacokinetics in Japanese subjects. The aim of the study was to determine the anticoagulation intensity of rivaroxaba...

Full description

Saved in:
Bibliographic Details
Published in:PLoS One
Main Authors: Okata, Takuya, Toyoda, Kazunori, Okamoto, Akira, Miyata, Toshiyuki, Nagatsuka, Kazuyuki, Minematsu, Kazuo
Format: Artigo
Language:Inglês
Published: Public Library of Science 2014
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4257912/
https://ncbi.nlm.nih.gov/pubmed/25479967
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0113641
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items